INTRODUCTION
Two genetic syndromes have been identified in which there is complete absence of beta lipoproteins from plasma (1) . In one of these, recessive abetalipoproteinemia, clinical features are manifest only in the homozygous state. In that disorder, normal chylomicrons, very low density lipoproteins (VLDL),1 and low density lipoproteins (LDL) are absent from plasma. A small amount of an abnormal lipoprotein, which can be concentrated from the low density untracentrifugal interval, appears to be derived from high density lipoproteins (HDL) (1) (2) (3) (4) . Clinical features include severe malabsorption of triglycerides (5) , acanthocytosis of erythrocytes (often with autohemolysis) (1, 6) , de- ficiency of tocopherols and often other fat soluble vitamins in plasma, retinopathy (7) , and progressive neurological disease (1) . In a genetically distinct disorder, familial hypobetalipoproteinemia, levels of LDL in plasma are approximately half-normal in the heterozygous state with moderate or absent clinical findings. However, a disease essentially indistinguishable from recessive abetalipoproteinemia occurs in the homozygous state (1, 8, 9) . Recently, a genetic disorder with severe hypobetalipoproteinemia but with nearly normal absorption of triglycerides has been described (10) . In this report we present a distinct, new syndrome, which we term normotriglyceridemic abetalipoproteinemia, in which normal LDL are absent, but in which intestinal absorption of triglycerides and the secretion of chylomicrons into plasma are intact.
Recently, we have demonstrated that the large proteins of human serum lipoproteins termed apolipoprotein B are heterogeneous (11) , a finding now shown also for the rat (12) . Normal VLDL contain a species with an apparent molecular weight of 549,000, which we denote the B-100 protein in a centile system of nomenclature, whereas the predominant species in chylomicrons has a molecular weight of 246,000 (denoted the B-48 protein). The amino acid compositions of these proteins are distinctly different. The B-48 protein is completely absent from normal human LDL, which contains, in addition to the B-100 protein, two other species, B-74 and B-26, which appear to be complementary fragments of B-100.
The primary molecular defect in the new form of abetalipoproteinemia described here appears to be deletion of the B-100 protein. The ability of the intestine to elaborate the B-48 protein is intact, permitting normal transport of triglyceride from the intestine in chylomicrons. The genetic control of the B-48 protein thus appears to be separate from that of the B-100 species.
METHODS
Description of the patient. The patient was referred at 8 yr of age because she was found to have levels of cholesterol and triglycerides in serum of25 and 30 mg/dl, respectively. No leta lipoprotein was seen on agarose gel electrophoresis of serumii. Lipoproteins with alpha and prebeta mobility were present, however. A chylomicron layer appeared after overnight refrigeration of serum obtained 4 to 8 h after an oral fat load.
In striking contrast with other syndromes of abetalipoproteinemia, this child was obese (Fig. 1) . Her weight was above the 97th percentile, and her height was at the 75th percentile. She had alternating esotropia, genu valgum, and a wide-based ataxic gait. She was retarded, with a mental age of 2 to 3 yr. Physical examination, aside from the features noted above, was within normal limits. She does not have the abnormality of hair, dentition, and skin described in a patient with a disorder of beta lipoproteins associated with abnormal tryptophan metabolism (13) . Stigmata ofautoimmune hypolipidemia were absent. She has a normal 46 XX karyotype. Relatives of this adopted child are not available for study.
Retinal studies, including routine and dark adapted electroretinograms, were normal. In both eyes, B wave amplitudes of 120 ,uV at 22 ms were observed uinder standard light adapted conditionis. After tive peak). The latter responses are in the low normal range (greater than twice the light adapted response). Motor nerve (peroneal) conduction velocity was 53 M/s and sensory nerve (sural) conduction was 50 M/s with normal action potential.
Serum protein electrophoresis and immunoelectrophoresis were normal. Cryoprecipitates were absent and the serum level ofthe third component ofcomplement was normal (155 mg/dl). Minimal stomatocytic changes were observed in some circulating erythrocytes with no more than 1% acanthocytes present (Fig. 2) .
While the patient was eating a typical American diet, her 72-h stool fat excretioni was -10 g. Radiograms of the stomach and duodenu-m with small bowel follow-through were normal, and a peroral biopsy of the small intestine 16 h after an oral fat load showed normal architecture, with no accumulation of lipid in the terminal villar region, a state compatible with normal chylomicron formation (Fig. 3) Instrumilenits, Palo Alto, Calif.) at the following solvent densities: 1.006, 1.063, and 1.21 g/cm3 (15) . Each lipoprotein fraction was obtained by flotation through an overlayer solution of KBr at the appropriate density and was purified by a second uiltracentrifugationi at the same density. KBr (17) . Individual classes of phospholipids were separated by the method of Dalal et al. (18) and quantified by determination of lipid phosphorus.
Lipoprotein atialysis. Serumil and lipoprotein fractions were subjected to electrophoresis in agarose gel (19, 21) . The conitenit of' apolipoprotein B in the lipoprotein fractions was measured by insoltubility in 1,1',3,3'-tetramethylurea (TMU) (20) . The conitenit of'TMU-soluble apoproteins was determined by electrophoresis in polyacrylamide gels (20) , and the isoformls of' apoproteini (apo) E were quanitified by isoelectric f'oeussinig (21) . A comiiparison of the immutnoreactivity of the patienit's serutm and lipoprotein fractions with that of normal serumtl was mlade by double immunodiff'usioni (22) , usinlg goat aintisertumil to whole htuman apo LDL. A series of dilutions of' each samiiple wats examiiined and a semi-quanititative estimate of' equivalence was determined from the respective dilutions which gave precipitin arcs of similar intensity. The contents of proline-rich apolipoprotein (23) , apolipoprotein A-I (24), and apolipoprotein D (25) in whole serum were determined immunochemically. Lp(a) specific antigen was detected by double immunodiffusion. Structure of the lipoproteins of the three density intervals was studied by electron microscopy of preparations negatively stained with 2% potassium phosphotungstate (26) . The flotation properties of high density lipoproteins were examined by analytical ultracentrifugation (27) .
Apolipoprotein The detailed composition of phospholipids in the three ultracentrifugally separated lipoprotein fractions described in Table I are shown in Table II . In each fraction the percent content of sphingomyelin is increased above normal at the expense of phosphatidylcholine as described in recessive abetalipoproteinemia (2) and homozygous hypobetalipoproteinemia (34) . The post-heparin lipolytic activity of plasma drawn after a 14-h fast was only 0.046 ,umol/ml per min, compared with that of a normal control of 0.21 ,smol/ml per min. In the presence of 1 M NaCl, the lipolytic activity of the patient's plasma was 0.038 ,umol/ml per min.
Electron microscopic appearance of lipoproteins. Electron photomicrographs of the lipoproteins in the ultracentrifugal fractions of the patient's serum are shown in Fig. 4 The mobility of the TMU-insoluble protein from the patient's d < 1.006 g/cm3 lipoprotein fraction in SDSgel electrophoretograms is shown in Fig. 5 . The predominant protein is present as a narrow band with mobility identical to that of the B-48 protein of human chylomicrons. The B-100 protein normally found in VLDL and LDL is absent, as are the B-74 and B-26 proteins normally found in LDL. The minor band in the lower portion of the gel appears to correspond to one of the elements of lower molecular weight found in chylomicrons. (This material has not been isolated in sufficient amounts for analysis.) The apparent molecular weight of the predominant TMU-insoluble protein in the patient's lipoproteins was estimated by its volume of elution from the preparative SDS-gel electrophoresis apparatus as shown in Fig. 6 . Its elution volume was identical to that of the B-48 protein derived from human thoracic duct chylomicrons. This corresponds to an apparent molecular weight of 264,000+8,150. The amino acid compositions of two preparations of the patient's 264,000 mol wt component, isolated by preparative SDS-gel electrophoresis, are shown in Table III . The contents of many of the amino acids do not differ greatly between the hepatogenous B-100 and enterogenous B-48 proteins. However, in those cases where distinct differences are apparent (glycine, alanine, methionine, isoleucine, and phenylalanine), the content in the patient's protein is close to that of the normal B-48 protein.
Despite the increase of triglycerides in plasma which occurred during carbohydrate feeding, the SDS-gel pattern of the patient's apo B remained unchanged. 
DISCUSSION
The syndrome described here differs from the two forms of abetalipoproteinemia reported previously (1, 36) in that essentially normal levels of triglycerides are present in plasma, and intestinal absorption oftriglycerides is normal. Also, in contrast to the syndrome of severe hypobetalipoproteinemia with normal absorption of triglycerides described by Steinberg et al. (10), our patient's serum is devoid of normal LDL. Despite the presence of triglyceride-rich lipoproteins in plasma, the syndrome which we describe here shares a number of features with the other two forms of abetalipoproteinemia, recessive abetalipoproteinemia and homozygous hypobetalipoproteinemia. In both, the ratio of sphingomyelin to phosphatidylcholine in plasma is increased (2, 34) . In the disorder we describe, this phenomenon is evident in the d < 1.006 g/Cm3 lipoprotein fraction as well as in the HDL. As in recessive abetalipoproteinemia (1, 4), homozygous hypobetalipoproteinemia (1), and the syndrome described by Steinberg et al. (10) , the lipoproteins are deficient in the monosialated form of apo C-III. This observation is consistent with the hypothesis, based on studies of inhibition of VLDL secretion in the rat with orotic acid (37) , that apo C-IIIl is primarily secreted from the liver with VLDL, whereas apo C-Ill2 is secreted with HDL. Levels of total HDL are decreased in this syndrome, a finding common to the three disorders mentioned above. In contrast to recessive abetalipoproteinemia, however, where levels of lipoproteins with flotation properties of HDL2 are nearly normal but the HDL3 fraction is markedly decreased (2, 4, 38), HDL2 lipoproteins are virtually absent and levels of HDL3 are low in normotriglyceridemic abetalipoproteinemia. The low level of apo D we have observed in plasma in this disorder may be related to the abnormalities of HDL. Post-heparin lipolytic activity has been found to be low in recessive abetalipoproteinemia (39, 40) . It has been postulated that this might reflect lack ofinduction due to deficiency of triglyceride-bearing lipoproteins in plasma. The low levels of activity we have observed in normotriglyceridemic abetalipoproteinemia in the presence of normal secretion of chylomicrons, suggests that some other factor is responsible. Certainly this is not due to deficiency ofapo C-II cofactor because the contents of that protein which we have observed in the d < 1.006 g/Cm3 lipoprotein fraction and in HDL considerably exceed the levels which appear to be required for activation of the enzyme (40 (43) . This is supported by similar findings with rat apo B (12) . The B apoprotein present in the patient's serum has the same apparent molecular weight (264,000) as does normal human intestinal B-48 protein, whereas that of the B-100 species is 549,000. The absence of the B-74 and B-26 proteins, which are probably complementary fragments of the B-100 molecule, further underscores the categorical deletion of the B-100 protein. Also, the amino acid composition of the patient's apo B is similar to that of the B-48 protein. Thus, it appears that the intestinal apolipoprotein B-48 is completely spared in this disorder, allowing the secretion and peripheral metabolism of chylomicrons to proceed normally. This suggests that the B-100 and B-48 proteins are under separate genetic control. The absence of B-100 protein in the patient's serum indicates that she must be homozygous for deletion of that protein. Studies of her family members would be important in evaluating this hypothesis because both parents would thus be obligate heterozygotes for the deletion. Unfortunately, none of the patient's relatives have been found for study.
The reactivity of B-48 protein with antibodies raised against apo B of LDL indicates that these proteins contain a common subunit. However, the observation that the immunoreactivity of B-48 with these antisera is considerably less than that of B-100 suggests that B-48 contains subunit protein which does not occur in the B-100 protein. The deletion of the apo B-100-containing species of lipoproteins in this disorder affords a unique opportunity to study the metabolism of triglyceride-rich lipoproteins of intestinal origin. The absence of normal LDL indicates that, unlike VLDL, chylomicrons are not normally converted to LDL. The small amount of intermediate density lipoprotein present suggests that only some chylomicron remnants enter the intermediate density interval or that they are removed very rapidly from plasma. The observation that levels of triglycerides in the patient's plasma increase threefold during 5 d of feeding a fat-free hypercaloric diet is not readily explained without further studies. It is possible that the liver is capable of producing the B-48 protein when the production of B-100 is blocked, and hence that the increase oftriglycerides in plasma could reflect the presence of abnormal hepatogenous VLDL. Other possibilities are that the patient's intestine may be the site of production of the triglyceride-rich particles following conversion of the carbohydrate to fatty acids in situ, or that removal of triglyceride-rich lipoproteins from plasma is impeded during carbohydrate loading.
The extremely low levels of tocopherol in the patient's plasma before supplmentation was given indicate that there is a defect in tocopherol transport despite the apparently normal formation of chylomicrons, presumably reflecting a requirement for VLDL or LDL. The observation that levels of tocopherols in the patient's plasma increased to normal during supplementation with 400 mg dl alpha tocopherol/d indicates that if a defect in absorption of tocopherol is present, it can be overcome by increasing intake of the vitamin. At the same time, the striking coincident improvement of the patient's ataxia suggests that this neurological defect may have been due to tocopherol deficiency. This experience is consistent with observations of amelioration or stabilization of neurological and retinal manifestations of abetalipoproteinemia during treatment with tocopherols (44, 45) . Normal levels of vitamin A in serum and normal prothrombin times suggest that transport of vitamin A and vitamin K are normal in normotriglyceridemic abetalipoproteinemia.
